Fitbit’s ECG app cleared for sale in the U.S. and EU

2020-09-15T15:46:00

Fitbit has earned regulatory clearance in the U.S. and the EU for an electrocardiogram (ECG) app that detects atrial fibrillation, or AFib – an irregularity of the heartbeat that can increase the risk of a stroke. Specifically, the device has received 510(k) clearance from the U.S. Food and Drug Administration ...

You’ve read your 2 free articles this month

Register  a free account or login  to unlock 3 more articles each week

SIGN-IN if you are already a subscriber of SGI Europe.

Gated access promo

Register today and unlock 3 more articles each week

See what industry leaders read every day:

  • Curated industry intelligence  you won’t find anywhere else—selected from 500+ sources
  • Exclusive interviews, case studies, and consumer insights  on emerging markets and trends
  • Expert analysis  on corporate moves, financials, retail trends, regulation, and innovation
  • The Daily Digest —essential sporting goods news delivered every morning

Register for free

Already a subscriber? Sign in

Ready for unlimited coverage?

Upgrade to Professional or Premium for unlimited access to exclusive reports,
C-suite interviews, market analysis, and industry-wide research—with team licensing included.

Compare subscription plans

Already registered? Sign in here